Inhaled corticosteroids in COPD: friend or foe?

Alvar Agusti, Leonardo M. Fabbri, Dave Singh, Jørgen Vestbo, Bartolome Celli, Frits M.E. Franssen, Klaus F. Rabe, Alberto Papi

Source: Eur Respir J, 52 (6) 1801219; 10.1183/13993003.01219-2018

Journal Issue: December

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alvar Agusti, Leonardo M. Fabbri, Dave Singh, Jørgen Vestbo, Bartolome Celli, Frits M.E. Franssen, Klaus F. Rabe, Alberto Papi. Inhaled corticosteroids in COPD: friend or foe?. Eur Respir J, 52 (6) 1801219; 10.1183/13993003.01219-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Infection: friend or foe to the development of asthma? Source: Eur Respir J 2001; 18: 744-747 Year: 2001
Inhaled therapies: can they breathe new life into asthma? Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019
Long-acting bronchodilators in COPD: where are we now and where are we going? Source: Breathe 2014; 10:110-120 Year: 2014
Inhaled beta2-agonists in asthma management: an evolving story Source: Breathe 2016; 12: 375-377 Year: 2016
Inhaled corticosteroids in treatment of patients with intermittent bronchial asthma: yes or no? Source: Eur Respir J 2005; 26: Suppl. 49, 503s Year: 2005
Inflammation: friend or foe of muscle remodelling in COPD? Source: Eur Respir J 2007; 30: 605-607 Year: 2007
FeNO for the diagnosis of asthma: foe Source: Virtual Congress 2021 – Fractionated exhaled nitric oxide for the diagnosis of asthma: friend or foe? Year: 2021
Optimising bronchodilator therapy in COPD: Who, why and when? Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care Year: 2019
What to use INSTEAD of inhaled corticosteroids in COPD? Source: Eur Respir J 2014; 44: 1391-1393 Year: 2014
Inhaled medication: which device for which patient? Source: Eur Respir Monogr 2015; 69: 213-223 Year: 2015
Treating bronchiolitis: should we choose between epinephrine and beta-agonists? Source: Eur Respir J 2001; 18: Suppl. 33, 169s Year: 2001
Inhaled corticosteroids in COPD: the case against Source: Eur Respir J 2009; 34: 13-16 Year: 2009
Inhaled beta2-agonists and death for asthma: can we overcome this risk? Source: Annual Congress 2007 - Effect of long acting beta-agonists on severe asthma exacerbations and asthma-related deaths Year: 2007
Bacterial colonisation in COPD: friend or foe? Source: Annual Congress 2010 - PG11 Postgraduate Course: Infection: a player in the natural history of COPD Year: 2010
Steroids in COPD: still up in the air? Source: Eur Respir J 2010; 35: 949-951 Year: 2010
Inhaled corticosteroids in COPD: the final verdict is… Source: Eur Respir J, 52 (6) 1801940; 10.1183/13993003.01940-2018 Year: 2018
Inhaled corticosteroids in COPD: a case in favour Source: Eur Respir J 2009; 34: 10-12 Year: 2009